Influenza Bulletin
NATIONAL WEEKLY INFLUENZA BULLETIN OF THE RUSSIAN FEDERATION
week 40 of 2025 (29.09.25 - 05.10.25)
Summary
Influenza and ARI incidence data. Influenza and other ARI activity in Russia decreased in comparison with previous week. The nationwide ILI and ARI morbidity level (67.9 per 10 000 of population) was lower than national baseline (82.9) by 18.1%.
Etiology of ILI & ARI. Among 7507 patients investigation, 15 (0.2%) respiratory samples were positive for influenza, including 8 cases of unsubtyped influenza A in 4 cities, 1 case of influenza A(H1N1)pdm09 in 1 city, 5 cases of influenza A(H3N2) in 3 cities and 1 case of influenza B in 1 city.
1 influenza virus A(H3N2) was isolated on MDCK cell culture in Saint-Petersburg NIC. Since the beginning of the season 1 influenza virus A(H3N2) was isolated.
Antigenic characterization. Since the beginning of the season 1 influenza A(H1N1)pdm09 has been antigenically characterized by the NICs. Virus was similar to the reference strain A/Victoria/4897/22 recommended in the vaccines for the Northern Hemisphere countries for the 2025-2026 season.
ARVI detections. The overall proportion of respiratory samples tested positive for other ARVI (PIV, ADV, RSV, RhV, CoV, MPV, BoV) was estimated in total as 19.2% (PCR).
In sentinel surveillance system clinical samples from 22 SARI patients were investigated by rRT-PCR for influenza, among them no positive cases were recognized. Among 22 SARI patients no positive cases of coronavirus SARS-CoV-2 were recognized. Among 22 SARI samples 5 (22.7%) cases of RhV were detected.
Among from 36 ILI/ARI patients no positive cases of influenza were recognized. Among 36 ILI/ARI samples 3 (8.3%) cases of RhV infection were detected. Among 36 ILI/ARI patients no positive cases of coronavirus SARS-CoV-2 were recognized.
COVID-19. The Federal Operational Headquarters for Combating the Novel Coronavirus Infection has discontinued the publication of weekly COVID-19 morbidity reports starting from epidemiological week 12.2025. This decision is due to the stabilization of the epidemiological situation regarding COVID-19 and the transition of the virus to the category of seasonal respiratory infections.
According to the data obtained by NIC in Saint-Petersburg totally 9901 clinical samples were PCR investigated in last week. Among them coronavirus SARS-CoV-2 was detected in 384 (3.9%) cases.
Influenza and ARI morbidity data

Weeks
-
Morbidity 2025/26
-
Morbidity 2024/25
-
MEM baseline 2025/26
Epidemiological data showed decreased of influenza and other ARI activity in Russia in comparison with previous week. The nationwide ILI and ARI morbidity level (67.9 per 10 000 of population) was lower than national baseline (82.9) by 18.1%.

Weeks
-
Season 2025/26
-
Season 2024/25
-
MEM baseline
Incidence rate of clinically diagnosed influenza decreased comparing to previous week and amounted to 0.042 per 10 000 of population, it was lower than pre-epidemic MEM baseline (0.45).

Weeks
-
Season 2025/26
-
Season 2024/25
-
MEM baseline
Hospitalization rate of clinically diagnosed influenza decreased comparing to previous week and amounted to 0.0051 per 10 000 of population, it was lower than pre-epidemic MEM baseline (0.099).
Influenza and ARVI laboratory testing results
Cumulative results of influenza laboratory diagnosis by rRT-PCR were submitted by 44 RBLs and two WHO NICs. According to these data as a result of 7507 patients investigation 15 (0.2%) respiratory samples were positive for influenza, including 8 cases of unsubtyped influenza A in 4 cities, 1 case of influenza A(H1N1)pdm09 in 1 city, 5 cases of influenza A(H3N2) in 3 cities and 1 case of influenza B in 1 city.
1 influenza virus A(H3N2) was isolated on MDCK cell culture in Saint-Petersburg. Since the beginning of the season 1 influenza virus A(H3N2) was isolated.
Antigenic characterization. Since the beginning of the season 1 influenza A(H1N1)pdm09 has been antigenically characterized by the NICs. Virus was similar to the reference strain A/Victoria/4897/22 recommended in the vaccines for the Northern Hemisphere countries for the 2025-2026 season.

-
No data
-
No viruses detected
-
H1pdm09
-
H3
-
H3+H1pdm09
-
B
-
B+H1pdm09
-
B+H3
-
B+H3+H1pdm09
-
A (not subt.)
-
A (not subt.)+H1pdm09
-
A (not subt.)+H3
-
A (not subt.)+H3+H1pdm09
-
A (not subt.)+B
-
A (not subt.)+B+H1pdm09
-
A (not subt.)+B+H3
-
A (not subt.)+B+H3+H1pdm09

Weeks
-
H1pdm09
-
H3
-
B
-
A (not subt.)
-
% positive

Weeks
-
PIV
-
ADV
-
RSV
-
RhV
-
CoV
-
MPV
-
BoV
ARVI detections. The overall proportion of respiratory samples tested positive for other ARVI (PIV, ADV, RSV, RhV, CoV, MPV, BoV) was estimated 19.2% of investigated samples by PCR.

Weeks
-
H1pdm09
-
H3
-
B
-
% positive
Table 1. Results of influenza and other ARVI detection by RT-PCR in Russia, week 40 of 2025
Number of specimens / number of positive cases | % positive | |
Influenza | ||
Number of specimens tested for influenza | 7507 | - |
Influenza A (not subt.) | 8 | 0,1% |
Influenza A(H1)pdm09 | 1 | 0,01% |
Influenza A(H3) | 5 | 0,07% |
Influenza B | 1 | 0,01% |
All influenza | 15 | 0,2% |
Other ARVI | ||
Number of specimens tested for ARVI | 7239 | - |
PIV | 118 | 1,6% |
ADV | 53 | 0,7% |
RSV | 10 | 0,1% |
RhV | 1033 | 14,3% |
CoV | 70 | 1,0% |
MPV | 47 | 0,6% |
BoV | 57 | 0,8% |
All ARVI | 1388 | 19,2% |
SARS-CoV-2 (COVID-19) | ||
Number of specimens tested for SARS-CoV-2 | 9901 | - |
SARS-CoV-2 | 384 | 3,9% |

-
No data
-
less then 10%
-
10-20%
-
20-30%
-
30-40%
-
40-50%
-
50% and more
COVID-19. The Federal Operational Headquarters for Combating the Novel Coronavirus Infection has discontinued the publication of weekly COVID-19 morbidity reports starting from epidemiological week 12. This decision is due to the stabilization of the epidemiological situation regarding COVID-19 and the transition of the virus to the category of seasonal respiratory infections. According to the data obtained by NIC in Saint-Petersburg totally 9901 clinical samples were PCR investigated in last week. Among them coronavirus SARS-CoV-2 was detected in 384 (3.9%) cases.
Table 2. Results of influenza viruses isolation in Russia, week 40 of 2025
Number of specimens / number of viruses | % isolated viruses | |
Number of specimens | 15 | - |
Influenza A(H1)pdm09 | 0 | 0,0% |
Influenza A(H3) | 1 | 6,7% |
Influenza B | 0 | 0,0% |
All influenza | 1 | 6,7% |
Sentinel influenza surveillance
Clinical samples from 22 SARI patients were investigated by rRT-PCR for influenza, among them no positive cases were recognized. Among 22 SARI patients no positive cases of coronavirus SARS-CoV-2 were recognized. Among 22 SARI samples 5 (22.7%) cases of RhV were detected.
Among 36 ILI/ARI patients no positive cases of influenza were recognized. Among 36 ILI/ARI samples 3 (8.3%) cases of RhV infection were detected. Among 36 ILI/ARI patients no positive cases of coronavirus SARS-CoV-2 were recognized.

Weeks
-
H1pdm09
-
H3
-
B
-
A (not subt.)
-
% positive

Weeks
-
H1pdm09
-
H3
-
B
-
A (not subt.)
-
% positive

Weeks
-
PIV
-
ADV
-
RSV
-
RhV
-
CoV
-
MPV
-
BoV

Weeks
-
PIV
-
ADV
-
RSV
-
RhV
-
CoV
-
MPV
-
BoV